1-3 of 3
Karim Benhadji
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeted FGFR Inhibition Results in Hematologic and Cytogenetic Remission in a Myeloid Neoplasm Driven By a Novel PCM1-FGFR1 Fusion: Data from an Expanded Access Program

Monica Kasbekar, Valentina Nardi, MD, Paola Dal Cin, Andrew M. Brunner, MD, Yi-Bin Chen, Christine Connolly, Amir T. Fathi, MD, Julia Foster, ANP, Molly Macrae, Steven L McAfee, MD, Kristin McGregor, Rupa Narayan, Aura Y. Ramos, Tina T. Som, RN, Megan Vartanian, RN, Robb S Friedman, MD, Karim Benhadji, MD MSC, Gabriela S. Hobbs, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5371.
https://doi.org/10.1182/blood-2019-124100
Published: 2019
Journal Articles

Enzastaurin in Previously Treated Waldenstrom's Macroglobulinemia: An Open-Label, Multicenter, Phase II Study.

Irene M Ghobrial, Jean-Luc Harousseau, Steven P Treon, Brianna Harris, Courtney E Lin, Zheng Yuan, Karim Benhadji, James E Wooldridge, Veronique Leblond
Journal: Blood
Blood (2009) 114 (22): 3867.
https://doi.org/10.1182/blood.V114.22.3867.3867
Published: 2009
Journal Articles

Enzastaurin Displays Activity against Follicular Lymphoma Cells: Role of mTOR Pathway

Samar Kheirallah, Loic Ysebaert, Ludivine Leseux, Karim Benhadji, Guy Laurent, MD, Christine Bezombes
Journal: Blood
Blood (2008) 112 (11): 2609.
https://doi.org/10.1182/blood.V112.11.2609.2609
Published: 2008